Ophthalmology · San Juan, PR
NPI
1679561047
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
357 Ave de la Constitucion, Puerta de Tierra
San Juan, PR, 00901
Phone (787) 289-6600
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
594 services
Medicare patients, 2024
255
Average age 78
Drug cost, 2024
$238K
4,521 prescriptions
Company payments, 2025
$26.03
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Federico A Maestre Grau was code 92012 (ophthalmological e&m), 422 times for 211 patients. In total Federico A Maestre Grau billed 594 services in 18 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 422 | 211 | $58.87 | $25K |
| 92004 Ophthalmological E&M | Office | 58 | 58 | $89.05 | $5,165 |
| 92133 Computerized Ophthalmic Imaging | Office | 44 | 35 | $24.21 | $1,065 |
| 92134 Computerized Ophthalmic Imaging | Office | 32 | 32 | $27.42 | $877 |
By year: 2022 $39K for 572 services; 2023 $41K for 613 services; 2024 $37K for 594 services.
Medicare prescription drug claims, 2024
In 2024, the drug Federico A Maestre Grau prescribed most often to Medicare patients was Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat), with 1,144 prescriptions and refills. In total Federico A Maestre Grau wrote 4,521 Medicare prescriptions that cost $238K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,144 | 1,992 | 304 | $38K |
| Timolol Maleate Generic | 803 | 872 | 169 | $11K |
| Latanoprost Generic | 412 | 535 | 91 | $6,001 |
| Lumigan Bimatoprost | 250 | 278 | 59 | $66K |
| Prednisolone Acetate Generic | 240 | 301 | 120 | $9,037 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 227 | 258 | 170 | $4,024 |
| Ketorolac Tromethamine Generic | 177 | 209 | 130 | $3,985 |
| Brimonidine Tartrate Generic | 147 | 166 | 38 | $2,724 |
| Ciprofloxacin Hcl Generic | 146 | 175 | 65 | $1,716 |
| Dexamethasone Sodium Phosphate Generic | 128 | 145 | 110 | $6,039 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 106 | 117 | 36 | $14K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 88 | 92 | 19 | $9,909 |
| Acetazolamide Generic | 82 | 84 | 46 | $1,295 |
| Combigan Brimonidine Tartrate/Timolol | 81 | 87 | 23 | $17K |
| Dorzolamide Hcl Generic | 67 | 113 | 19 | $2,110 |
Brand drugs: 887 claims; generic drugs: 3,634 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Federico A Maestre Grau $26.03 ($26.03 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $26.03.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $26.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.